Don Healey - 04 Oct 2022 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Reporting relationship: Chief Technology Officer
Issuer ticker: ACET
Reported as of: 04 Oct 2022
Net transaction value: -$112,807
SEC form: 4
Accepted by SEC: 04 Oct 2022, 17:20:06 UTC
Prior SEC filing: 08 Aug 2022
Next SEC filing: 26 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Nick Harvey, Attorney-in-Fact

Key filing fact

Don Healey filed Form 4 for Adicet Bio, Inc. (ACET) on 04 Oct 2022.

Key facts

This page summarizes Don Healey's Form 4 filing for Adicet Bio, Inc. (ACET).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Oct 2022, 17:20.

Change

Previous filing in this sequence was filed on 08 Aug 2022.
Current net transaction value: -$112,807.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACET transaction

Common Stock

Tax liability

Transaction value: $112,807
Shares: -7,933
Change %: -13%
Price: $14.22^*
Shares after: 55,468
Date: 04 Oct 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.